Testosterone After 40: TRT, “T-Boosters,” and What Actually Works — The SupplementDecider Reality Check
Testosterone is having a moment. Prescriptions have climbed, telehealth clinics advertise “low T” evaluations that take minutes, and social feeds are full of men describing testosterone therapy as the thing that gave them their energy back. Access has genuinely widened: a man who once needed a referral to an endocrinologist can now answer an online questionnaire, order a lab kit and be offered treatment without ever sitting in a clinic.
More access does not automatically mean more benefit. The questions worth asking are narrower and more useful: who actually needs treatment, and what can supplements realistically do?
This guide separates diagnosed hypogonadism from ordinary aging, explains how testosterone should be tested, summarises what prescription therapy can and cannot do (including the 2023 TRAVERSE cardiovascular trial and the FDA labelling changes of 2025 and June 2026), and grades the ingredients sold as over-the-counter testosterone boosters against human evidence. It is educational, not medical advice.
SupplementDecider Reality Check
Four lanes — find yours before you spend anything
Diagnosed low testosterone with symptoms
Treat with a clinicianTwo properly timed low morning measurements plus consistent symptoms or signs. Evidence-based treatment may be appropriate, with a plan for monitoring and a clear discussion of risks, benefits and fertility.
Low-normal testosterone, no clear symptoms
Do not chase a numberInvestigate sleep, weight change, medicines, alcohol, acute illness and timing of the blood draw, then repeat the test. Many low-normal readings normalise on a properly timed repeat.
Over-the-counter “T-booster” blends
Weak, inconsistent evidenceMost marketed ingredients failed to consistently increase total testosterone in human trials, and proprietary blends hide the doses that were studied in the first place.
Correcting a real nutrient deficiency
Reasonable — but not TRTRestoring a documented zinc or vitamin D deficiency supports normal physiology. It is not equivalent to testosterone therapy and should not be marketed as such.
Why testosterone is “on the rise”
Three things happened at once. Direct-to-consumer telehealth made hormone evaluation fast and private, removing the awkward conversation many men avoided for years. Marketing followed the demand, framing fatigue, softening muscle and flat mood as a single fixable hormone problem. And the science news cycle delivered a genuinely important trial — TRAVERSE — followed by two rounds of FDA label revisions that made testosterone look less dangerous than the previous decade of warnings had suggested.
All of that is real. None of it changes the underlying medicine: testosterone therapy is a treatment for a diagnosed condition, and the diagnosis is the part most often skipped.
What low testosterone actually means
Male hypogonadism is a clinical syndrome: consistently low testosterone plus symptoms or physical signs caused by that deficiency. Testosterone declines gradually with age in most men — roughly one percent a year on average from midlife — but an age-related drift downward is not the same as a disease, and most men in their fifties and sixties remain within the reference range.
Laboratories commonly flag total testosterone below about 300 ng/dL (10.4 nmol/L) for follow-up, but that cut-off varies with the assay and population. Sex hormone-binding globulin rises with age, which can make total testosterone look reassuring while free testosterone is lower than it appears — one reason interpretation belongs with a clinician rather than a results portal.
Symptoms that overlap with almost everything
The symptoms attributed to low testosterone are real, but they are not specific. Each one has a long list of other causes that are more common:
- Persistent fatigue and low energy — also sleep apnoea, anaemia, thyroid disease, depression, medication side effects.
- Reduced libido — also relationship strain, antidepressants, alcohol, chronic pain, depression.
- Erectile difficulty — frequently vascular, and often an early marker of cardiovascular disease or diabetes.
- Loss of muscle and strength — also inactivity, low protein intake, illness, unintentional weight loss.
- Low mood, irritability or brain fog — also poor sleep, stress, alcohol, mood disorders.
- Increased body fat, especially around the abdomen — which can itself lower measured testosterone.
More specific signs — loss of body hair, small or shrinking testicles, breast tenderness or enlargement, hot flushes, infertility — carry more diagnostic weight than fatigue alone.
Why diagnosis should never rest on symptoms alone
Online “low T quizzes” are built from exactly the non-specific symptoms above, which is why almost everyone who takes one screens positive. Treating a symptom list without confirming the hormone — and without looking for the other explanations — risks committing a man to a lifelong therapy for a problem he does not have, while the real cause goes unaddressed.
The testing rule
- At least two separate total testosterone measurements, both low, before any diagnosis is made.
- Drawn early in the morning — typically before 10 a.m. — when levels peak, and in a fasting state, because food can transiently lower readings.
- Not during acute illness, hospitalisation or an extreme training or dieting phase, all of which suppress levels temporarily.
- Using a reliable, well-calibrated assay; results are not always comparable between laboratories, and free testosterone should be measured by a validated method rather than estimated when accuracy matters.
- Interpreted alongside LH, FSH, prolactin and other tests your clinician selects to identify the cause.
Primary vs secondary — why the cause matters
Primary hypogonadism arises in the testes themselves (for example after mumps orchitis, chemotherapy, trauma, or in Klinefelter syndrome). LH and FSH are high because the pituitary is shouting at a gland that cannot respond.
Secondary hypogonadism comes from the pituitary or hypothalamus, with low or inappropriately normal LH and FSH. Common contributors include obesity, obstructive sleep apnoea, opioids, glucocorticoids, heavy alcohol use, chronic illness — and, less commonly, a pituitary tumour or high prolactin that must not be missed.
The distinction changes everything. Secondary causes are often partly reversible, and a man who wants children has meaningfully different options depending on which he has. Starting testosterone without that workup skips over both.
What TRT can and cannot do
Prescription testosterone reliably does one thing: it raises testosterone. In men with genuine hypogonadism, trials and clinical experience support improvements in sexual desire, and often modest gains in lean mass, strength, bone mineral density and self-reported energy or mood. Those effects are real but usually incremental, and they take months rather than days.
What it is not: a treatment for aging, a performance enhancer with a clean safety profile, or a reliable fix for erectile dysfunction in men whose testosterone is normal. It has not been shown to prevent cardiovascular disease, dementia, diabetes or frailty. In men with normal levels, benefits shrink toward nothing while the risks and the commitment stay.
TRAVERSE, read accurately
TRAVERSE (New England Journal of Medicine, 2023) randomised middle-aged and older men with hypogonadism and either established cardiovascular disease or high cardiovascular risk to testosterone gel or placebo. For the primary endpoint — major adverse cardiac events such as cardiovascular death, non-fatal myocardial infarction and non-fatal stroke — testosterone was non-inferior to placebo. That was reassuring, and it is why the previous class-wide cardiovascular boxed warning no longer stands.
It is not a clean bill of health. Several adverse events occurred more often in the testosterone group, including atrial fibrillation, acute kidney injury and pulmonary embolism. The trial studied a specific population using a specific gel formulation over a defined follow-up; it does not license testosterone use in men without hypogonadism, and it does not answer questions about very long-term use.
What changed on the label — 2025 and 2026
- February 2025: the FDA announced class-wide labelling changes for testosterone products. The boxed warning about cardiovascular risk was removed in light of TRAVERSE, while labelling added or retained warnings about increases in blood pressure based on ambulatory blood-pressure monitoring studies. Blood pressure is now an explicit monitoring item, not a footnote.
- June 18, 2026: HHS and the FDA requested further label revisions that removed the earlier limitation-of-use language discouraging treatment of age-related or idiopathic hypogonadism, and revised the prostate and benign prostatic hyperplasia information. This widened the labelled context for treatment; it did not establish that treating age-related decline benefits men, and long-term uncertainty plus the need for monitoring remain.
- July 2026: the Endocrine Society issued a statement reiterating that testosterone therapy belongs with a proper diagnosis — symptoms plus repeated, correctly timed low measurements — and with ongoing clinical follow-up.
Fertility is the decision men regret most
Exogenous testosterone suppresses LH and FSH, and with them sperm production. Counts can fall dramatically, sometimes to zero, and recovery after stopping can take many months and is not guaranteed. Any man who might want to father children — now or later — should raise this before the first prescription and ask about fertility-preserving alternatives with a urologist or reproductive endocrinologist.
What proper monitoring looks like
- Testosterone level rechecked to confirm the dose lands in the target range — not chased to the top of it.
- Haematocrit, because testosterone can thicken the blood; a rising haematocrit may require dose reduction or stopping.
- Blood pressure, in line with the 2025 labelling changes.
- Prostate risk assessment, including PSA where appropriate for the man's age and risk, with any new urinary symptoms reported.
- Symptom review — if the symptoms that justified treatment have not improved after an adequate trial, the diagnosis deserves revisiting.
- Adverse effects: acne, fluid retention, mood change, breast tenderness, worsening sleep apnoea, injection-site or application-site issues, and secondary transfer to partners or children from gels.
Do testosterone booster supplements work?
This is the category where marketing and evidence diverge most sharply. A 2024 systematic review examined 27 ingredients proposed as testosterone boosters and found that most did not consistently increase total testosterone in human trials. An earlier analysis of commercial “T booster” products found that many ingredient claims had no supporting human data at all, and that products routinely contained nutrient doses well above recommended intakes.
A few ingredients produced signals in limited populations or small studies. That is a reason for further research — not evidence that a commercial blend treats hypogonadism or improves anything a man would notice. Proprietary blends make this worse by hiding the per-ingredient dose, so even where a studied dose exists, you cannot tell whether the bottle contains it.
| Ingredient | What marketers claim | What human evidence suggests | Verdict |
|---|---|---|---|
| Zinc | “Essential for testosterone — more zinc, more T.” | Zinc is required for normal reproductive function, and correcting a documented deficiency can improve hormone status in deficient men. In men who are not deficient, added zinc has not reliably raised total testosterone. | Correct deficiency only |
| Vitamin D | “The sunshine hormone that restores testosterone.” | Observational studies link low vitamin D status with lower testosterone, but randomised trials in men who are not deficient have generally not shown a meaningful increase. Repletion is worth doing for bone and general health reasons. | Correct deficiency only |
| Magnesium | “Frees up bound testosterone.” | Small studies, often in athletes or magnesium-poor diets, report modest changes in measured testosterone. The evidence is thin, short and inconsistent, and does not support magnesium as a treatment for low testosterone. | Weak / inconsistent |
| Ashwagandha (Withania somnifera) | “Clinically proven to boost testosterone and vitality.” | One of the few ingredients with repeated randomised trials, mostly small, short and in stressed, overweight or infertile men, with mixed results for testosterone and better support for perceived stress. Not shown to treat hypogonadism. | Limited signal, not treatment |
| Tongkat ali (Eurycoma longifolia) | “Traditional male vitality herb that raises free T.” | Small trials, several in men with low baseline testosterone or high stress, report increases; study quality, extract standardisation and independence vary widely. Results have not been consistently reproduced. | Limited signal, low certainty |
| Fenugreek | “Boosts free testosterone and libido.” | Trials of proprietary extracts report improvements in self-reported libido more often than clear increases in total testosterone, and many are manufacturer-funded with small samples. | Weak for testosterone |
| Tribulus terrestris | “The classic testosterone herb.” | Among the most studied and most consistently negative: controlled trials in men generally show no meaningful increase in testosterone. | Not supported |
| D-aspartic acid | “Stimulates luteinising hormone and testosterone.” | Early short studies suggested a rise; better-controlled follow-up trials in resistance-trained men found no increase, and one reported a decrease at higher intake. | Not supported |
| Shilajit | “Ancient mineral resin that restores male hormones.” | A small number of short trials of purified preparations report changes in testosterone, with limited independent replication and questions about product purity and heavy-metal contamination. | Insufficient evidence |
Zinc, specifically
Zinc is genuinely required for normal reproductive function, and men with a documented deficiency can see hormone measures improve when it is corrected. That is deficiency correction — not a universal testosterone booster. The NIH Office of Dietary Supplements lists the recommended dietary allowance for adult men at 11 mg per day and the tolerable upper intake level for adults at 40 mg per day from all sources combined.
Many “T-booster” products exceed that upper limit in a single serving. Chronic excess zinc can cause copper deficiency — which can lead to anaemia and neurological problems — and may reduce immune function and lower HDL cholesterol. Zinc also interferes with certain antibiotics and with penicillamine. Take the amount your intake or blood work justifies, not the amount a label uses as a marketing signal.
What may move the needle without a T-booster
None of the following is guaranteed to normalise testosterone, and none is a substitute for evaluating a real deficiency. They are, however, the levers with the best supporting evidence — and they improve the same symptoms men blame on testosterone, whatever the hormone turns out to be doing.
- Resistance training two to three times a week, progressively loaded. The strongest, most reliable route to preserving muscle mass, strength and function after 40.
- Sleep: adequate duration and consistency. Testosterone is produced largely during sleep, and short or fragmented sleep lowers it in controlled studies.
- Investigate and treat sleep disorders — obstructive sleep apnoea in particular is common, under-diagnosed, and closely tied to both low testosterone and fatigue.
- Avoid crash dieting and chronic undernutrition; severe energy restriction suppresses the hormonal axis.
- Address obesity where it is present. Weight loss is associated with increases in measured testosterone, though the size of the change varies a great deal between individuals.
- Moderate heavy alcohol use, which affects both the testes and the liver's handling of hormones.
- Review medications and conditions with a clinician — opioids, glucocorticoids, some antidepressants, poorly controlled diabetes and chronic illness all sit behind a meaningful share of low readings.
The Low-T Decision Path
Work down the questions in order. Each step exists to stop the most common mistake: treating a number instead of a person.
- 1
Do you have persistent symptoms or physical signs?
Yes → Continue to testing with a clinician who will also look for other explanations.
No → Routine testing is not recommended for men without symptoms. Focus on sleep, weight, activity and medication review.
- 2
Two properly timed low tests (early morning, fasting)?
Yes → The picture is consistent with hypogonadism — the next question is why.
No → One low reading is not a diagnosis. Repeat the test correctly before anything else.
- 3
Is there a reversible cause?
Yes → Address it first: untreated sleep apnoea, significant weight gain, opioids or glucocorticoids, heavy alcohol use, crash dieting, acute illness or poorly controlled diabetes can all lower measured testosterone.
No → Move on to establishing whether the problem is testicular (primary) or pituitary/hypothalamic (secondary).
- 4
Do you want to father children now or later?
Yes → Do not casually start exogenous testosterone. Ask for a referral to discuss fertility-preserving options before treatment.
No → Fertility should still be documented in the conversation — plans change.
- 5
Confirmed hypogonadism?
Yes → Discuss individualised treatment, realistic goals, monitoring schedule and risks with your clinician.
No → Skip the expensive booster stacks. Put the money and effort into the underlying causes.
The SupplementDecider verdict
Graded on our five-point evidence scale: Strong, Promising, Mixed, Weak, Not Recommended. The category as a whole scores Mixed — because the right answer depends entirely on whether a diagnosis exists.
Prescription TRT for confirmed hypogonadism
Strong evidence that it raises testosterone. Symptom benefit depends on the individual and the condition being treated. Requires medical supervision, a monitoring plan, and a fertility conversation first.
Generic OTC testosterone-booster blends
Weak and inconsistent human evidence. Most ingredients did not reliably raise total testosterone, and proprietary blends obscure the doses that were studied.
Correcting proven nutrient deficiencies
A sensible supportive strategy when blood work or intake shows a genuine shortfall. Supports normal physiology; it is not testosterone therapy and should not be sold as such.
Safety: read this before you order anything
Testosterone is a prescription hormone, not a supplement. Do not self-treat based on one lab value, an online quiz, or a product sold without a clinician involved.
- Fertility: exogenous testosterone suppresses sperm production, sometimes for many months after stopping.
- Haematocrit: testosterone can raise red cell mass; an elevated haematocrit needs dose adjustment or discontinuation.
- Blood pressure: labelling carries blood-pressure warnings based on ambulatory monitoring studies — check it regularly.
- Sleep apnoea: discuss existing or suspected apnoea before starting; symptoms can worsen.
- Prostate: agreed monitoring, including PSA where appropriate, and prompt reporting of new urinary symptoms.
- Cardiovascular and clotting history: atrial fibrillation, acute kidney injury and pulmonary embolism were more frequent with testosterone in TRAVERSE — relevant if you already carry that risk.
- Full medication and medical history, including anticoagulants, glucocorticoids and opioids.
- Unregulated sources, veterinary or research-labelled products, and clinics that prescribe without repeat morning testing should be avoided outright.
How SupplementDecider evaluates men’s-health supplements
- 1Standardised ingredients: a named extract with a stated standardisation, not a generic herb name on a panel.
- 2Transparent per-ingredient doses — we down-rate proprietary blends automatically, because a hidden dose cannot be compared with a studied one.
- 3Third-party testing for identity, potency and contaminants; independent verification programmes carry more weight than in-house claims.
- 4Human clinical evidence in a relevant population, preferably randomised, independently funded and replicated — animal and cell data do not count toward a verdict.
- 5Claims that match the evidence. Any product marketed as a substitute for medical evaluation of low testosterone fails on that basis alone.
- 6Safety and interaction review, including upper intake limits for nutrients such as zinc.
We do not sell supplements, list prices, or recommend a men’s-health product we have not reviewed. See How We Review Supplements.
Frequently asked questions
What testosterone level is considered low?
There is no single universal cut-off. Most laboratories and guidelines treat a total testosterone below roughly 300 ng/dL (about 10.4 nmol/L) as the threshold that prompts further evaluation, but reference ranges differ by assay and laboratory. A diagnosis is not made from one number: it requires consistent symptoms or physical signs plus at least two low measurements taken early in the morning in a fasting state, ideally on separate days, using a reliable assay.
Can supplements really raise testosterone?
Rarely in any meaningful way. A 2024 systematic review of 27 ingredients marketed as testosterone boosters found that most did not consistently increase total testosterone in human trials. A few ingredients showed signals in small or selected populations, but that is not evidence that a commercial blend treats hypogonadism or improves symptoms. Correcting a genuine nutrient deficiency — zinc or vitamin D, for example — supports normal physiology, which is different from raising testosterone in someone who is not deficient.
Is TRT safe for the heart?
The TRAVERSE trial found that in middle-aged and older men with hypogonadism and existing cardiovascular disease or high cardiovascular risk, testosterone gel was non-inferior to placebo for major adverse cardiac events. However, some adverse events — atrial fibrillation, acute kidney injury and pulmonary embolism — occurred more often in the testosterone group. In 2025 the FDA removed the class-wide boxed cardiovascular warning while adding or retaining blood-pressure warnings based on ambulatory blood-pressure studies. Long-term safety questions remain, so monitoring matters.
Does testosterone therapy affect fertility?
Yes. Exogenous testosterone suppresses the hormonal signals that drive sperm production and can substantially reduce or stop sperm output, sometimes for months after stopping. Men who want to father children should not casually start testosterone; a urologist or reproductive endocrinologist can discuss alternatives that preserve fertility.
Should every man over 40 get his testosterone checked?
No. Population-wide screening of men without symptoms is not recommended. Testing makes sense when there are persistent symptoms or physical signs that fit hypogonadism, or specific conditions that raise the likelihood of it. Testing a symptom-free man often finds a low-normal number that leads to treatment nobody needed.
What is the best supplement for low testosterone?
There is no supplement that reliably treats diagnosed low testosterone. Confirmed hypogonadism is a medical condition managed by a clinician. If blood work shows a real deficiency of a nutrient such as vitamin D or zinc, correcting it is reasonable on its own merits — but that is deficiency correction, not testosterone therapy.
References
- [1]Endocrine Society. Statement on testosterone replacement therapy and diagnosis (July 16, 2026).
- [2]Endocrine Society. Clinical practice guideline resource: testosterone therapy.
- [3]U.S. Food and Drug Administration. Testosterone Information (updated 2026).
- [4]U.S. Department of Health and Human Services. FDA requests updates to testosterone therapy labeling (June 18, 2026).
- [5]U.S. Food and Drug Administration. FDA issues class-wide labeling changes for testosterone products (February 28, 2025).
- [6]Lincoff AM, et al. Cardiovascular safety of testosterone-replacement therapy (TRAVERSE). N Engl J Med. 2023.
- [7]Morgado A, et al. Systematic review of proposed testosterone boosters. Int J Impot Res. 2024.
- [8]Clemesha CG, et al. ‘Testosterone boosting’ supplements composition and claims: a review. 2019.
- [9]NIH Office of Dietary Supplements. Zinc fact sheet for consumers.
Medical disclaimer
This article is educational and is not medical advice. It does not diagnose, treat or prevent any condition, and it is not a substitute for evaluation by a qualified clinician. Testosterone therapy is a prescription treatment with real risks. Supplements can interact with prescription medicine and are not appropriate for everyone. Talk to your physician or pharmacist before starting, stopping or changing anything you take. Read our full medical disclaimer.
Related reading
Medication safety
Do Herbal Supplements Thin Your Blood? What the Evidence Shows About Bleeding Risk
ReadMedication safety
Supplements and Medications: The Interactions Adults Over 50 Should Know
ReadMedication safety
When Medicine Changes Your Nutrient Needs After 50
ReadStart with our Supplements After 50 hub for the full healthy-aging reading path.